Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Provided here is a protocol for investigating the interactions between native form, prefibrillar, and mature amyloid fibrils of different peptides and proteins with mitochondria isolated from different tissues and various areas of the brain.

Abstract

A growing body of evidence indicates that membrane permeabilization, including internal membranes such as mitochondria, is a common feature and primary mechanism of amyloid aggregate-induced toxicity in neurodegenerative diseases. However, most reports describing the mechanisms of membrane disruption are based on phospholipid model systems, and studies directly targeting events occurring at the level of biological membranes are rare. Described here is a model for studying the mechanisms of amyloid toxicity at the membrane level. For mitochondrial isolation, density gradient medium is used to obtain preparations with minimal myelin contamination. After mitochondrial membrane integrity confirmation, the interaction of amyloid fibrils arising from α-synuclein, bovine insulin, and hen egg white lysozyme (HEWL) with rat brain mitochondria, as an in vitro biological model, is investigated. The results demonstrate that treatment of brain mitochondria with fibrillar assemblies can cause different degrees of membrane permeabilization and ROS content enhancement. This indicates structure-dependent interactions between amyloid fibrils and mitochondrial membrane. It is suggested that biophysical properties of amyloid fibrils and their specific binding to mitochondrial membranes may provide explanations for some of these observations.

Introduction

Amyloid-related disorders, known as amyloidoses, constitute a large group of diseases defined by the appearance of insoluble protein deposits in different tissues and organs1,2. Among them, neurodegenerative disorders are the most frequently forms in which protein aggregates appear in the central or peripheral nervous system2. Although a number of mechanisms have been proposed to be involved in the toxicity of amyloid aggregates3, a growing body of evidence points to cell membrane disruption and permeabilization as the primary mechanism of amyloid pathology

Protocol

All animal experiments were performed in accordance with the Institutional Animal Care and Use Committee (IACUC) of Medical Sciences of Tehran University. Maximal efforts were made to minimize suffering and detrimental effects to the rats by sharpening the guillotine blades and applying resolute and swift movements of the blade.

1. Brain homogenization and mitochondrial isolation

NOTE: All reagents for mitochondrial isolation were prepared according to Sims and Anders.......

Representative Results

The protocol describes a model for studying the interactions of amyloid fibril with rat brain mitochondria as an in vitro biological model. For mitochondrial preparation, 15% (v/v) density gradient medium was used to remove myelin as major contamination of brain tissue14. As shown in Figure 1A, centrifugation at 30,700 x g produced two distinct bands of material, myelin (as the major component of band 1) and band 2, which.......

Discussion

A wealth of experimental results supports the hypothesis that the cytotoxicity of fibrillar aggregates is significantly associated with their ability to interact with and permeabilize biological membranes4,5. However, most of the data are based on artificial lipid bilayers that do not necessarily reflect the intrinsic properties of biological membranes, which are heterogeneous structures with a wide variety of phospholipids and proteins. Here, using brain mitocho.......

Acknowledgements

This work was supported by grants from the Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.

....

Materials

NameCompanyCatalog NumberComments
2′,7′-Dichlorodihydrofluorescein diacetateSigma35845
Ammonium sulfateMerck1012171000
Black 96-well plateCorning
Black Clear-bottomed 96-well plateCorning
Bovine insulinSigmaI6634
Bovine Serum Albumin (BSA)SigmaA2153
BSA essentially fatty acid-freeSigmaA6003
CentrifugeSigma
Crystal clear sealing tapeCorning
CuSO4Sigma451657
Dialysis bag (cut off 2 KDa)SigmaD2272
Dounce homogenizerPotter Elvehjem
EDTASigmaE9884
Fluorescence plate readerBioTek
Fluorescence spectrophotometerCary Eclipse VARIAN
FolinMerckF9252
GlycineSigmaG7126
GuillotineMade in Iran
HClMerckH1758
Hen Egg White Lysozyme (HEWL)SigmaL6876
Na2CO3SigmaS7795
NaH2PO4SigmaS7907
NaOHMerckS8045
OxaloacetateSigmaO4126
PercollGE Healthcare
Phosphate Buffer Saline (PBS)SigmaCS0030
PMSFSigmaP7626
Potassium sodium tartrateSigma217255
Quartz cuvetteSigma
Spectrophotometeranalytik jenaSPEKOL 2000 model
SuccinateSigmaS2378
SucroseMerck1076871000
ThermomixerEppendorph
Thioflavin TSigmaT3516
Tris-HClMerck1082191000
Triton X-100SigmaT9284
TryptoneQUELAB
Water bathMemmert
Yeast ExtractQUELAB
β-NADHSigmaN8129

References

  1. Merlini, G., Bellotti, V. Molecular mechanisms of amyloidosis. New England Journal of Medicine. 349, 583-596 (2003).
  2. Berg, I. . Modeling amyloid disease in Drosophila melanogaster, Linköping Studies in Science and Technology Dissertation No. 1320. , (2010).
  3. Kagan....

Explore More Articles

MitochondriaAmyloid FibrilsAlpha synucleinMembrane PermeabilizationNeurodegenerative DiseasesBrainIsolationHomogenizationCentrifugationDensity GradientMyelinMitochondrial Fraction

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved